Plasma transforming growth factor beta1 in breast cancer patients treated with CMF chemotherapy
- 1 August 2000
- journal article
- research article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 25 (4) , 291-294
- https://doi.org/10.1046/j.1365-2710.2000.00290.x
Abstract
Background: In early breast cancer patients the transformed epithelial cells are thought to be sensitive to transforming growth factor β1 (TGFβ1)‐mediated growth arrest. TGFβ1 may therefore act as a...Keywords
This publication has 17 references indexed in Scilit:
- Increased Transforming Growth Factor β1 Plasma Level in Patients with Renal Cell Carcinoma:A Tumor-Specific Marker?Urologia Internationalis, 1998
- TGFβ-1 regulation of VEGF production by breast cancer cellsAnnals of Surgical Oncology, 1997
- Transforming growth factor-β in breast cancer: A working hypothesisBreast Cancer Research and Treatment, 1997
- The Expression of Vascular Endothelial Growth Factor and Transforming Growth Factor-β Associates With Angiogenesis in Epithelial Ovarian CancerInternational Journal of Gynecological Pathology, 1997
- Serum Transforming Growth Factor-beta 1 in Patients With Renal Cell CarcinomaJournal of Urology, 1997
- TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expressionBreast Cancer Research and Treatment, 1997
- Transforming Growth Factor Beta 1 is Significantly Elevated in Plasma of Patients Suffering from Renal Cell CarcinomaCytokine, 1996
- Regulation and Role of TGFβ Production in Breast CanceraAnnals of the New York Academy of Sciences, 1996
- The multifunctional role of transforming growth factor (TGF)-ßs on mammary epithelial cell biologyBreast Cancer Research and Treatment, 1996
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995